Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Pneumonia | Research

Healthcare-associated infection prevention and control practices in Israel: results of a national survey

Authors: Ronza Najjar-Debbiny, Bibiana Chazan, Rona Lobl, M. Todd Greene, David Ratz, Sanjay Saint, Yehuda Carmeli, Mitchell J. Schwaber, the Israel IPC Working Group

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Healthcare-associated infection (HAI) is a common and largely preventable cause of morbidity and mortality. The COVID-19 pandemic has presented unprecedented challenges to health systems. We conducted a national survey to ascertain hospital characteristics and the use of HAI prevention measures in Israel.

Methods

We e-mailed surveys to infection prevention and control (IPC) leads of acute care hospitals in Israel. The survey included questions about the use of practices to prevent catheter-associated urinary tract infection (CAUTI), central line-associated bloodstream infection (CLABSI), ventilator-associated pneumonia (VAP), and Clostridioides difficile infection (CDI). The survey also assessed COVID-19 impact and healthcare worker well-being.

Results

IPC leads from 15 of 24 invited hospitals (63%) completed the survey. Only one-third of respondents reported strong support for IPC from hospital leadership. Although several prevention practices were used by all hospitals (e.g., maximum sterile barrier precautions for CLABSI and real-time assessment of environmental cleaning for CDI), use of other practices was suboptimal—particularly for CAUTI and VAP. COVID-19 had a profound impact on Israeli hospitals, with all hospitals reporting opening of new units to care for COVID patients and most reporting moderate to extreme financial hardship. All hospitals reported highly successful plans to vaccinate all staff and felt confident that the vaccine is safe and effective.

Conclusion

We provide a status report of the IPC characteristics and practices Israeli hospitals are currently using to prevent HAIs during the COVID-19 era. While many globally accepted IPC practices are widely implemented, opportunities to increase the use of certain IPC practices in Israeli hospitals exist.
Appendix
Available only for authorised users
Literature
1.
go back to reference Al-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014;7(4):339–44.CrossRef Al-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014;7(4):339–44.CrossRef
2.
go back to reference Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, Haller S, Harder T, Klingeberg A, Sixtensson M, et al. Burden of six healthcare-associated infections on European Population Health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med. 2016;13(10): e1002150.CrossRef Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, Haller S, Harder T, Klingeberg A, Sixtensson M, et al. Burden of six healthcare-associated infections on European Population Health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med. 2016;13(10): e1002150.CrossRef
3.
go back to reference Krein SL, Kowalski CP, Hofer TP, Saint S. Preventing hospital-acquired infections: a national survey of practices reported by U.S. hospitals in 2005 and 2009. J Gen Intern Med. 2012;27(7):773–9.CrossRef Krein SL, Kowalski CP, Hofer TP, Saint S. Preventing hospital-acquired infections: a national survey of practices reported by U.S. hospitals in 2005 and 2009. J Gen Intern Med. 2012;27(7):773–9.CrossRef
4.
go back to reference Saint S, Kowalski CP, Kaufman SR, Hofer TP, Kauffman CA, Olmsted RN, Forman J, Banaszak-Holl J, Damschroder L, Krein SL. Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin Infect Dis. 2008;46(2):243–50.CrossRef Saint S, Kowalski CP, Kaufman SR, Hofer TP, Kauffman CA, Olmsted RN, Forman J, Banaszak-Holl J, Damschroder L, Krein SL. Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin Infect Dis. 2008;46(2):243–50.CrossRef
5.
go back to reference Krein SL, Kowalski CP, Damschroder L, Forman J, Kaufman SR, Saint S. Preventing ventilator-associated pneumonia in the United States: a multicenter mixed-methods study. Infect Control Hosp Epidemiol. 2008;29(10):933–40.CrossRef Krein SL, Kowalski CP, Damschroder L, Forman J, Kaufman SR, Saint S. Preventing ventilator-associated pneumonia in the United States: a multicenter mixed-methods study. Infect Control Hosp Epidemiol. 2008;29(10):933–40.CrossRef
6.
go back to reference Krein SL, Hofer TP, Kowalski CP, Olmsted RN, Kauffman CA, Forman JH, Banaszak-Holl J, Saint S. Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc. 2007;82(6):672–8.CrossRef Krein SL, Hofer TP, Kowalski CP, Olmsted RN, Kauffman CA, Forman JH, Banaszak-Holl J, Saint S. Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc. 2007;82(6):672–8.CrossRef
7.
go back to reference Krein SL, Olmsted RN, Hofer TP, Kowalski C, Forman J, Banaszak-Holl J, Saint S. Translating infection prevention evidence into practice using quantitative and qualitative research. Am J Infect Control. 2006;34(8):507–12.CrossRef Krein SL, Olmsted RN, Hofer TP, Kowalski C, Forman J, Banaszak-Holl J, Saint S. Translating infection prevention evidence into practice using quantitative and qualitative research. Am J Infect Control. 2006;34(8):507–12.CrossRef
8.
go back to reference Saint S, Greene MT, Fowler KE, Ratz D, Patel PK, Meddings J, Krein SL. What US hospitals are currently doing to prevent common device-associated infections: results from a national survey. BMJ Qual Saf. 2019;28(9):741–9.CrossRef Saint S, Greene MT, Fowler KE, Ratz D, Patel PK, Meddings J, Krein SL. What US hospitals are currently doing to prevent common device-associated infections: results from a national survey. BMJ Qual Saf. 2019;28(9):741–9.CrossRef
9.
go back to reference Vaughn VM, Saint S, Greene MT, Ratz D, Fowler KE, Patel PK, Krein SL. Trends in Health Care-Associated Infection Prevention Practices in US Veterans Affairs Hospitals from 2005 to 2017. JAMA Netw Open. 2020;3(2): e1920464.CrossRef Vaughn VM, Saint S, Greene MT, Ratz D, Fowler KE, Patel PK, Krein SL. Trends in Health Care-Associated Infection Prevention Practices in US Veterans Affairs Hospitals from 2005 to 2017. JAMA Netw Open. 2020;3(2): e1920464.CrossRef
10.
go back to reference Krein SL, Greene MT, Apisarnthanarak A, Sakamoto F, Tokuda Y, Sakihama T, Fowler KE, Ratz D, Saint S. Infection prevention practices in Japan, Thailand, and the United States: results from national surveys. Clin Infect Dis. 2017;64(suppl_2):S105–11.CrossRef Krein SL, Greene MT, Apisarnthanarak A, Sakamoto F, Tokuda Y, Sakihama T, Fowler KE, Ratz D, Saint S. Infection prevention practices in Japan, Thailand, and the United States: results from national surveys. Clin Infect Dis. 2017;64(suppl_2):S105–11.CrossRef
11.
go back to reference Greene MT, Krein SL, Huis A, Hulscher M, Sax H, Sakamoto F, Sakihama T, Tokuda Y, Fowler KE, Saint S. Infection prevention practices in the United States, the Netherlands, Switzerland, and Japan: results from national surveys. Infect Control Hosp Epidemiol. 2021;42(10):1206–14.CrossRef Greene MT, Krein SL, Huis A, Hulscher M, Sax H, Sakamoto F, Sakihama T, Tokuda Y, Fowler KE, Saint S. Infection prevention practices in the United States, the Netherlands, Switzerland, and Japan: results from national surveys. Infect Control Hosp Epidemiol. 2021;42(10):1206–14.CrossRef
13.
go back to reference Sakamoto F, Asano K, Sakihama T, Saint S, Greene MT, Patel P, Ratz D, Tokuda Y. Changes in health care-associated infection prevention practices in Japan: results from 2 national surveys. Am J Infect Control. 2019;47(1):65–8.CrossRef Sakamoto F, Asano K, Sakihama T, Saint S, Greene MT, Patel P, Ratz D, Tokuda Y. Changes in health care-associated infection prevention practices in Japan: results from 2 national surveys. Am J Infect Control. 2019;47(1):65–8.CrossRef
14.
go back to reference Sax H, Schreiber PW, Clack L, Ratz D, Saint S, Greene MT, Kuster SP. Preventing healthcare-associated infection in Switzerland: results of a national survey. Infect Control Hosp Epidemiol. 2020;41(5):597–600.CrossRef Sax H, Schreiber PW, Clack L, Ratz D, Saint S, Greene MT, Kuster SP. Preventing healthcare-associated infection in Switzerland: results of a national survey. Infect Control Hosp Epidemiol. 2020;41(5):597–600.CrossRef
15.
go back to reference Apisarnthanarak A, Ratz D, Greene MT, Khawcharoenporn T, Weber DJ, Saint S. National survey of practices to prevent health care-associated infections in Thailand: the role of prevention bundles. Am J Infect Control. 2017;45(7):805–10.CrossRef Apisarnthanarak A, Ratz D, Greene MT, Khawcharoenporn T, Weber DJ, Saint S. National survey of practices to prevent health care-associated infections in Thailand: the role of prevention bundles. Am J Infect Control. 2017;45(7):805–10.CrossRef
16.
go back to reference Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338(8763):339–43.CrossRef Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338(8763):339–43.CrossRef
17.
go back to reference Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136(11):792–801.CrossRef Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136(11):792–801.CrossRef
18.
go back to reference Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15(4):231–8.CrossRef Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15(4):231–8.CrossRef
19.
go back to reference Klompas M, Branson R, Cawcutt K, Crist M, Eichenwald EC, Greene LR, Lee G, Maragakis LL, Powell K, Priebe GP, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(6):687–713.CrossRef Klompas M, Branson R, Cawcutt K, Crist M, Eichenwald EC, Greene LR, Lee G, Maragakis LL, Powell K, Priebe GP, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(6):687–713.CrossRef
20.
go back to reference Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(Suppl 2):S48-65.CrossRef Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(Suppl 2):S48-65.CrossRef
21.
go back to reference Rohde JM, Jones K, Padron N, Olmsted RN, Chopra V, Dubberke ER. A tiered approach for preventing Clostridioides difficile infection. Ann Intern Med. 2019;171(7_Suppl):S45–51.CrossRef Rohde JM, Jones K, Padron N, Olmsted RN, Chopra V, Dubberke ER. A tiered approach for preventing Clostridioides difficile infection. Ann Intern Med. 2019;171(7_Suppl):S45–51.CrossRef
22.
go back to reference Dimitriu MCT, Pantea-Stoian A, Smaranda AC, Nica AA, Carap AC, Constantin VD, Davitoiu AM, Cirstoveanu C, Bacalbasa N, Bratu OG, et al. Burnout syndrome in Romanian medical residents in time of the COVID-19 pandemic. Med Hypotheses. 2020;144:109972.CrossRef Dimitriu MCT, Pantea-Stoian A, Smaranda AC, Nica AA, Carap AC, Constantin VD, Davitoiu AM, Cirstoveanu C, Bacalbasa N, Bratu OG, et al. Burnout syndrome in Romanian medical residents in time of the COVID-19 pandemic. Med Hypotheses. 2020;144:109972.CrossRef
23.
go back to reference Prasad K, McLoughlin C, Stillman M, Poplau S, Goelz E, Taylor S, Nankivil N, Brown R, Linzer M, Cappelucci K, et al. Prevalence and correlates of stress and burnout among U.S. healthcare workers during the COVID-19 pandemic: a national cross-sectional survey study. EClinicalMedicine. 2021;35:100879.CrossRef Prasad K, McLoughlin C, Stillman M, Poplau S, Goelz E, Taylor S, Nankivil N, Brown R, Linzer M, Cappelucci K, et al. Prevalence and correlates of stress and burnout among U.S. healthcare workers during the COVID-19 pandemic: a national cross-sectional survey study. EClinicalMedicine. 2021;35:100879.CrossRef
Metadata
Title
Healthcare-associated infection prevention and control practices in Israel: results of a national survey
Authors
Ronza Najjar-Debbiny
Bibiana Chazan
Rona Lobl
M. Todd Greene
David Ratz
Sanjay Saint
Yehuda Carmeli
Mitchell J. Schwaber
the Israel IPC Working Group
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07721-8

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.